Reply to: "Obtaining first-line induction in autoimmune hepatitis: Aren't we underestimating prednisolone?"

J Hepatol. 2024 Oct 5:S0168-8278(24)02580-7. doi: 10.1016/j.jhep.2024.09.040. Online ahead of print.

Authors

Charlotte D Slooter¹, Anna E C Stoelinga², Romée J A L M Snijders³

Affiliations

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
² Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
³ Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands; European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Electronic address: [email protected].

PMID: 39369859
DOI: 10.1016/j.jhep.2024.09.040

No abstract available

Publication types

Letter